QAIR logo

QleanAir AB (publ) Stock Price

OM:QAIR Community·SEK 292.7m Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

QAIR Share Price Performance

SEK 19.70
-1.10 (-5.29%)
SEK 31.00
Fair Value
SEK 19.70
-1.10 (-5.29%)
36.5% undervalued intrinsic discount
SEK 31.00
Fair Value
Price SEK 19.70
AnalystConsensusTarget SEK 31.00

QAIR Community Narratives

·
Fair Value SEK 31 36.5% undervalued intrinsic discount

Expansion Into US Cleanroom Segment Will Open Future Opportunities

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
SEK 31
36.5% undervalued intrinsic discount
Revenue
9.36% p.a.
Profit Margin
12.49%
Future PE
8.44x
Price in 2029
SEK 38.75

Trending Discussion

No trending discussion available.

Updated Narratives

QAIR logo

QAIR: US Healthcare Cleanroom Contracts Will Support Future Upside Potential

Fair Value: SEK 31 36.5% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with reasonable growth potential.

3 Risks
4 Rewards

QleanAir AB (publ) Key Details

SEK 452.1m

Revenue

SEK 142.3m

Cost of Revenue

SEK 309.8m

Gross Profit

SEK 280.9m

Other Expenses

SEK 28.9m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 25, 2026
1.95
68.52%
6.39%
75.0%
View Full Analysis

About QAIR

Founded
1988
Employees
120
CEO
Sebastian Lindström
WebsiteView website
www.qleanair.com

QleanAir AB (publ) provides air cleaning solutions for indoor environments in Sweden and internationally. The company operates through three segments: Air Cleaners, Cabin Solutions and Cleanrooms. It offers freestanding air cleaners for professional environments; freestanding smoking cabins for protection against secondhand smoke; and freestanding room-within-a-room turnkey cleanroom solutions under the QleanAir and QleanSpace names. The company’s solutions are used in warehouses and logistics centers, schools, offices, high security facilities and institutions, transport and airports, hotels, casinos, and restaurants, as well as food, manufacturing, assembly, aerospace, healthcare, drug preparation, pharmaceutical, manufacturing, BioTech, Offshore, shopping malls, Production, MedTech, and life science industries. The company was formerly known as QleanAir Holding AB (publ) and changed its name to QleanAir AB (publ) in July 2021. QleanAir AB (publ) was founded in 1988 and is headquartered in Solna, Sweden.

Recent QAIR News & Updates

Narrative Update Jun 24

QAIR: US Healthcare Cleanroom Contracts Will Support Future Upside Potential

Analysts have maintained their SEK 31.0 price target for QleanAir, with only minor adjustments to inputs such as the discount rate, revenue growth, profit margin and future P/E assumptions supporting their view. What’s in the News for QleanAir QleanAir signed two US healthcare agreements to build modular cleanrooms compliant with USP 797 and USP 800 standards, including a first project with a multi state specialty compounding pharmacy operator and a continued partnership with a hospital in Texas.
Narrative Update Jun 05

QAIR: US Healthcare Cleanroom Contracts And Legal Resolution Will Support Upside

Analysts have kept their SEK price target for QleanAir broadly in line with prior views, reflecting largely unchanged assumptions on fair value, discount rate, revenue growth, profit margin and future P/E. This signals a steady outlook on the stock based on current information.
Narrative Update May 16

QAIR: US Healthcare Cleanroom Pipeline And Legal Settlement Will Drive Upside

Analysts have trimmed their price target on QleanAir from SEK35 to SEK31, citing updated assumptions for revenue growth, profit margins, the discount rate, and future P/E levels. What's in the News QleanAir signed an agreement with one of the largest academic medical centers in the US for a USP 797 and 800 compliant modular cleanroom for pharmacy compounding in a specialty pharmacy setting, the customer's fourth cleanroom project with the company, with completion expected by the end of the first quarter of 2027 (Key Developments).

Recent updates

No updates